- |||||||||| albutropin (TV-1106) / Teva
Enrollment change, Trial termination: Study of TV-1106 in Growth Hormone-Deficient Adults (clinicaltrials.gov) - Apr 28, 2016 P3, N=14, Terminated, Active, not recruiting --> Terminated; Business decision N=180 --> 14 | Active, not recruiting --> Terminated; Business decision
- |||||||||| albutropin (TV-1106) / Teva
Trial primary completion date: Study of TV-1106 in Growth Hormone-Deficient Adults (clinicaltrials.gov) - Mar 5, 2016 P3, N=180, Active, not recruiting, N=140 --> 34 | Active, not recruiting --> Terminated; Business decision Trial primary completion date: Jan 2018 --> Mar 2016
- |||||||||| albutropin (TV-1106) / Teva
Enrollment closed: Study of TV-1106 in Growth Hormone-Deficient Adults (clinicaltrials.gov) - Feb 27, 2016 P3, N=180, Active, not recruiting, Trial primary completion date: Apr 2017 --> Mar 2016 Recruiting --> Active, not recruiting
- |||||||||| albutropin (TV-1106) / Teva
Enrollment closed: A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children (clinicaltrials.gov) - Oct 8, 2015 P2, N=60, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
|